Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Primary fallopian tube carcinoma (PFTC) in a BRIP-1 mutation carrier: the first case report.

Familial cancer - 1 Oct 2020

Grandi Giovanni, Caroli Martina, Alboni Carlo, Cortesi Laura, Toss Angela, Barbieri Elena, Botticelli Laura, Facchinetti Fabio

Abstract excerpt

Some hereditary ovarian cancer cases can be associated with a mutation of a gene involved in the DNA double-strand break repair system other than BRCA, such as BRIP1. This mutation is an emerging indication for prophylactic risk-reducing salpingo-oophorectomy (RRSO): however, anomalous tubal pathologic lesions have not yet been reported during RRSO performed for this specific indication (BRIP1), as largely...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Asymptomatic Diseases
Share to Cystadenocarcinoma, Serous

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Fallopian Tube Neoplasms

Share to Fanconi Anemia Complementation Group Proteins

Share to Genes, BRCA2

Share to Neoplasm Grading

Share to RNA Helicases

Share to Salpingo-oophorectomy

Source

Identifiers

PMID: 32328861
DOI: 10.1007/s10689-020-00179-0

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Primary fallopian tube carcinoma (PFTC) in a BRIP-1 mutation carrier: the first case report.PMID 32328861Read ↗

Peritoneal cancer risk after risk reducing salpingo-oophorectomy, impact of mutational status and STIC lesions.Semantic proximity Read ↗

Support of the 'fallopian tube hypothesis' in a prospective series of risk-reducing salpingo-oophorectomy specimens.Semantic proximity Read ↗

Specialist oncological surgery for removal of the ovaries and fallopian tubes in BRCA1 and BRCA2 pathogenic variant carriers may reduce primary peritoneal cancer risk to very low levels.Semantic proximity Read ↗

Serous tubal intraepithelial carcinoma in a Japanese woman with a deleterious BRCA1 mutation.Semantic proximity Read ↗

Risk-reducing salpingo-oophorectomy (RRSO) in BRCA mutation carriers: experience with a consecutive series of 111 patients using a standardized surgical-pathological protocol.Semantic proximity Read ↗

[Oncopathological aspects of BRCA1 and BRCA2 genes inactivation in tumors of ovary, fallopian tube and pelvic peritoneum].Semantic proximity Read ↗

BRIP1 loss-of-function mutations confer high risk for familial ovarian cancer, but not familial breast cancer.Semantic proximity Read ↗

The Role of Routine Peritoneal and Omental Biopsies at Risk-Reducing Salpingo-Oophorectomy.Semantic proximity Read ↗

The founder mutation BRCA1c.2845insA identified in a fallopian tube cancer patient: a case report.Semantic proximity Read ↗

[Don't forget fallopian tubes! A morphologic and immunohistochemical study about Fallopian tubes with genetic risk (BRCA mutation)].Semantic proximity Read ↗

[Early epithelial lesions in prophylactic annexectomies in patients at high risk of ovarian cancer: Report of a series of 93 cases].Semantic proximity Read ↗

Primary Peritoneal Serous Carcinoma in Men: A Rare and Non-BRCA-associated Entity.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.